Survey data detailing impact of off time and dyskinesia in people affected by parkinson's disease presented at american academy of neurology (aan) annual meeting

Tucson, ariz. & emeryville, calif.--(business wire)--parkinson & movement disorder alliance (pmd alliance, www.pmdalliance.org) and adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced findings from a survey on the impact of off time and dyskinesia, also known as parkinson's disease (pd) motor complications, presented at the american academy of ne
ADMS Ratings Summary
ADMS Quant Ranking